ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,519Medicare Part D Prescriptions Filled, Including Refills

Rank: 63 out of 1844

$965K Total Retail Price of All Prescriptions

Rank: 55 out of 1844

386 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 386 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 13,708 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 629 562 1 1
FUROSEMIDE 628 583 2 7
WARFARIN SODIUM 519 509 3 13
LISINOPRIL 512 485 4 4
POTASSIUM CHLORIDE 420 404 5 16
OMEPRAZOLE 412 308 6 5
NAMENDA 348 348 7 33
AMLODIPINE BESYLATE 335 310 8 6
CARVEDILOL 304 293 9 22
METOPROLOL SUCCINATE 294 257 10 14
DONEPEZIL HCL 277 277 11 26
METOPROLOL TARTRATE 240 233 12 11
SIMVASTATIN 240 229 12 3
NYSTOP 227 219 14 185
MIRTAZAPINE 219 219 15 49
LANTUS 190 165 16 42
TAMSULOSIN HCL 188 154 17 27
SERTRALINE HCL 184 173 18 21
CITALOPRAM HBR 169 160 19 19
POLYETHYLENE GLYCOL 3350 169 157 19 39
PRAVASTATIN SODIUM 167 161 21 10
CYMBALTA 151 124 22 36
ALENDRONATE SODIUM 151 137 22 25
EXELON 148 137 24 112
ATORVASTATIN CALCIUM 147 115 25 12
PRENATABS RX 145 135 10 26 232
NOVOLOG 145 129 26 84
GABAPENTIN 143 135 28 15
CLOZAPINE 138 138 29 186
HYDROCODONE-ACETAMINOPHEN 125 68 S3 30 2
TRAMADOL HCL 125 107 30 18
ALLOPURINOL 120 110 32 29
ESCITALOPRAM OXALATE 117 116 33 52
ISOSORBIDE MONONITRATE ER 112 110 34 59
PANTOPRAZOLE SODIUM 108 105 35 32
CLOPIDOGREL 105 101 36 34
ADVAIR DISKUS 102 79 37 51
DIGOXIN 101 101 38 67
DOXYCYCLINE HYCLATE 98 78 39 90
LOSARTAN POTASSIUM 96 94 40 24
HYDROCHLOROTHIAZIDE 95 83 41 9
SPIRONOLACTONE 94 94 42 60
LEVETIRACETAM 92 79 43 105
FINASTERIDE 90 77 44 137
KLOR-CON M20 90 89 44 54
SULFAMETHOXAZOLE-TRIMETHOPRIM 89 75 46 73
CLONIDINE HCL 89 89 46 64
RISPERIDONE 89 61 46 65
METFORMIN HCL 79 53 49 8
PHENYTOIN SODIUM EXTENDED 77 64 50 147
CARBIDOPA-LEVODOPA 77 54 50 86
FAMOTIDINE 72 59 52 63
BUMETANIDE 71 71 53 121
CEPHALEXIN 70 68 54 56
CEFDINIR 70 64 54 169
FLUTICASONE PROPIONATE 69 48 56 50
NITROGLYCERIN PATCH 65 65 57 173
LEVOFLOXACIN 64 58 58 78
NYSTATIN 64 45 58 85
ATENOLOL 63 54 60 17
SINGULAIR 63 56 60 102
OLANZAPINE 63 63 60 117
PLAVIX 60 56 63 61
CELEBREX 59 40 64 91
DIOVAN 59 55 64 58
DILTIAZEM ER 59 56 64 200
PRADAXA 59 59 64 338
PREDNISONE 58 40 68 40
KLOR-CON M10 57 44 69 149
TRAZODONE HCL 55 53 70 43
GLIMEPIRIDE 54 47 71 35
IPRATROPIUM-ALBUTEROL 53 46 72 113
AZITHROMYCIN 51 43 73 37
BENAZEPRIL HCL 51 47 73 75
BACLOFEN 50 34 75 119
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.